Publication:
The utility of ga-68-psma pet/ct in poorly differentiated metastatic prostate cancer

Simple item page
dc.contributor.coauthorUçar, Burcu
dc.contributor.coauthorSağlıcan, Yeşim
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAcar, Ömer
dc.contributor.kuauthorDemirkol, Mehmet Onur
dc.contributor.kuauthorKiremit, Murat Can
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:59:47Z
dc.date.issued2017
dc.description.abstractWe aimed to emphasize how useful PSMA PET/CT findings can be while trying to restage prostate cancer after radical prostatectomy in the presence of low prostate-specific antigen values. A 64-year-old man with pT3b N1 M0 Gleason 7 adenocarcinoma of the prostate presented 5 years postoperatively with a palpable axillary mass, whereas his prostate-specific antigen was 0.08 ng/mL. Conventional imaging studies and histopathologic findings of the axillary mass biopsy revealed inconclusive results. Ga-68-PSMA PET/CT demonstrated PSMA-positive metastatic lesions, the largest one being located in the right axilla. This finding confirmed metastatic poorly differentiated prostate cancer, and androgen deprivation therapy was initiated.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue5
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume42
dc.identifier.doi10.1097/RLU.0000000000001617
dc.identifier.eissn1536-0229
dc.identifier.issn0363-9762
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85015658830
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000001617
dc.identifier.urihttps://hdl.handle.net/20.500.14288/15688
dc.identifier.wos399411600039
dc.keywordsGa-68
dc.keywordsProstate cancer
dc.keywordsProstate-specific membrane antigen membrane antigen
dc.keywordsTherapy
dc.keywordsTarget
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofClinical Nuclear Medicine
dc.subjectRadiology
dc.subjectNuclear medicine
dc.subjectMedical imaging
dc.titleThe utility of ga-68-psma pet/ct in poorly differentiated metastatic prostate cancer
dc.typeOther
dc.type.otherEditorial material
dspace.entity.typePublication
local.contributor.kuauthorDemirkol, Mehmet Onur
local.contributor.kuauthorKiremit, Murat Can
local.contributor.kuauthorAcar, Ömer
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext